To investigate the functional involvement of TP53INP1, LATS2 and CD44 in pancreatic cancer growth, shRNA-directed knockdown of TP53INP1, LATS2 and CD44 was performed and the effects on cell proliferation, migration and tumour growth were measured. This evidence concerns the gene TP53INP1 and familial pancreatic carcinoma.